The effect of estrogens on depression

Estrogen Effects in Psychiatric Disorders

Volumn , Issue , 2005, Pages 145-173

  Kahn, Linda S ^a   Halbreich, Uriel ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747884577     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-211-27063-9_7     Document Type: Chapter

References (173)

1. Abramowitz ES, Baker AH, Fleiscler S (1982) Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139: 475-478.
2. Angold A, Costello EJ, Erkanli A, Worthman CM (1999) Pubertal changes in hormone levels and depression in girls. Psychol Med 29: 1043-53.
3. Angold A, Costello EJ, Worthman CM (1998) Puberty and depression: The roles of age, pubertal status and pubertal timing. Psychol Med 28: 51-61.
4. Angst J, Frey R, Lohmeyer R, Zerben-Rubin E (1980) Bipolar manic depressive psychoses: results of a genetic investigation. Hum Genet 55: 237-254.
5. Appleby L, Gregoire A, Platz C (1994) Screening women for high risk postnatal depression. J Psychosom Res 38: 539-545.
6. Archer JS (1999) Relationship between estrogen, serotonin, and depression. Menopause 6: 71-78.
7. Aylward M, Holly F, Parker RI (1974) An evaluation of clinical response to piperazineoestronesulphate ("Harmogen") in menopausal patients. Curr Med Res Opin: 417.
8. Backstrom T, Landgren S, Zetterland B (1984) Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure, variation during the menstrual cycle. In: Porter RJ, Mattson RH, Ward AAJ (eds) Advances in epileptology. Raven Press, New York, 269-277.
9. Birge S (1997) The role of estrogen in the treatment of Alzheimer's disease. Neurology 48 (Suppl 7): S36-S41.
10. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157: 924-930.
11. Brayshaw ND, Brayshaw DD (1986) Thyroid hypofunction in premenstrual syndrome. N Engl J Med 315: 1486.
12. Brincat M, Studd JW, O'Dow W, Magos A, Cardozo LD, Wardle PJ (1984) Subcutaneous hormone implants for the control of climetric symptoms. Lancet: 160-168.
13. Brockington IF, Kelly A, Hall P (1988a) Premenstrual relapse puerperal psychosis. J Affect Disord 14: 287-292.
14. Brockington IF, Margison FR, Schofield EM, Knight RJE (1988b) The clinical picture of the depressed form of puerperal psychosis. J Affect Disord 15: 29-37.
15. Burvill PW (1995) Recent progress in the epidemiology of major depression. Epidemiol Rev 17: 21-31.
16. Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obset Gynaecol 4: 31-47.
17. Campbell S (1976) Double blind psychometric studies on the effects of natural estrogens on post-menopausal women. In: Campbell S (ed) The management of menopause and postmenopausal years. MTP, Lancaster, 149-158.
18. Carothers AD, Murray L (1990) Estimating psychiatric morbidity by logistic regression: Application to post-natal depression in a community sample. Psychol Med 20: 695-702.
19. Casper RF, Patel-Christopher A, Powell A (1989) Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab 68: 608-612.
20. Chakravorty SG, Halbreich U (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33: 229-233.
21. Coope I (1981) Is oestrogen therapy effective in the treatment of menopausal depression. J R Coll Gen Pract 31: 134-140.
22. Coope I (1981) The menopause. Is oestrogen therapy affective in the treatment of postmenopausal depression. J R Coll Gen Pract 31: 134-140.
23. Coope J, J.M. T, Poller L (1975) Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. BMJ 4: 139-143.
24. Cooper PJ, Murray L, Hooper R, West A (1996) The development and validation of a predictive index for postpartum depression. Psychol Med 26: 627-634.
25. Coppen A, Bishop M, Beard RJ (1977) Effects on piperazine oestrone sulphate on plasma tryptophan, oestrogens, gonadotrophins and psychological functioning in women following hysterectomy. Curr Med Res Opin 4: 29-36.
26. Cox JL, Connor Y, Kendell RE (1982) Prospective sudy of the psychiatric disorders of childbirth. Br J Psychiatry 140: 111-117.
27. Dahr V, Murphy BEP (1990) Double-blind randomized crossover trial of luteal phase estrogens (Premarin®). Psychoneuroendrocrinology 15: 489-493.
28. Dalton K (1964) The premenstrual syndrome. Heinemann, London.
29. Demyttenaere K, Lenaerts H, Nijs P, Van Assche FA (1995) Individual coping style and psychological attitudes during pregnancy predict depression levels during pregnancy and during postpartum. Acta Psychiatr Scand 91: 95-102.
30. Dennerstein L, Burrows GD (1979) Affect and the menstrual cycle. J Affect Disord 1: 77-92.
31. Derman RJ, Dawood MY, Stone S (1995) Quality of life during sequential hormone replacement therapy - A placebo-controlled study. Int J Fertil Menopausal Stud 40: 73-78.
32. Dickinson SL, Curzon G (1986) 5-Hydroxytryptamine-mediated behavior in male and female rats. Neuropharmacology 25: 771-776.
33. Ditkoff EC, Crary WG, Cristo M, Lobo R (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991-995.
34. d'Orban PT, Dalton J (1980) Violent crime and the menstrual cycle. Psychol Med 10: 353-359.
35. Endicott J, Halbreich U (1988) Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry 49: 486-489.
36. Epperson CN, Wisner KL, Yamamoto B (1999) Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676-697.
37. Fedor-Freybergh (1977) The influence on oestrogen on wellbeing and mental performance in climacteric postmenopausal women. Acta Obstet Gynecol Scand 64: 2-10.
38. Frank R (1931) The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053-1057.
39. Freeman E, Rickels K, Sondheimer SJ, Polansky M (1990) Ineffectiveness of progesterone suppository treatment for premenstrual syndrome: A placebo-controlled, randomized, double-blind study. JAMA 264: 349-353.
40. Freeman EW, Sondheimer SJ, Rickels K, Weinbaum PJ (1985) PMS treatment approaches and progesterone therapy. Psychosomatics 26: 811-816.
41. Friedman RC, Hurt SW, Charkin J (1982) Sexual histories and premenstrual affective syndrome in psychiatric inpatients. Am J Psychiatry 139: 1484-1486.
42. Furuhjelm M, Karlgren E, Carlstrom K (1984) The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 63: 655-661.
43. Garlow SJ, Musselman DJ, Nemeroff CB (1999) The neurochemistry of mood disorders: Clinical studies. In: Charney DS, Nestler EJ, Bunney BS (eds) Neurobiology of mental illness. Oxford University Press, New York.
44. George GCW, Utian WH, Beumont PJV, Bearwood CJ (1973) Effect of exogenous oestrogens on mionor psychiatric symptoms in postmenopausal women. S Afr Med J 47: 2387-2388.
45. Gerdes LC, Sonnendecker EWW, Polakow ES (1979) Psychological changes effected by estrogen-progestogen and chlonidine treatment in climacteric women. Am J Obstet Gynecol 1: 77-92.
46. Gladis MM, Walsh BT (1987) Premenstrual exacerbation of binge eating in bulimia. Psychiatry 144: 1592-1595.
47. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347: 930-3.
48. Gurguis GN, Yonkers KA, Blakeley JE, Phan SP, Williams A, Rush AJ (1998a) Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-Adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res 79: 31-42.
49. Gurguis GN, Yonkers KA, Phan SP, Blakeley JE, Williams A, Rush AJ (1998b) Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol Psychiatry 44: 600-609.
50. Halbreich U, Alt IH, Paul L (1988) Premenstrual changes. Impaired hormonal homeostasis. Neurol Clin 6: 173-94.
51. Halbreich U, Ben-David M, Assael M, Bornstein R (1976) Serum-prolactin in women with premenstrual syndrome. Lancet 02: 654-656.
52. Halbreich U, Carson S, Rojansky N, Lane J, Alt E (1988) 20% of women who reported premenstrual dysphoric changes might have subclinical hypothyroidism. Proc Annual Meeting of the American College of Neuropsychopharmacology (ACNP). San Juan, PR.
53. Halbreich U, Endicott J, Goldstein S, Nee J (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74: 576-586.
54. Halbreich U, Endicott J, Schacht S, Nee J (1982) The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatr Scand 65: 46-65.
55. Halbreich U, Endicott J (1985) Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71: 331-338.
56. Halbreich U, Lumley LA (1993) The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 29: 159-173.
57. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N (1993) Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 34: 676-686.
58. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434-441.
59. Halbreich U, Rojansky N, Palter S (1991) Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 56: 1066-1069.
60. Halbreich U, Smoller JW (1997) Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58: 399-402.
61. Halbreich U, Tworek H (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 23: 1-27.
62. Halbreich U (2000) Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry 57: 1163-1164.
63. Halbreich U (1995) Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 9: 163-175.
64. Halbreich U (1997a) Menstrually related disorders - towards interdisciplinary international diagnostic criteria. Cephalalgia 17 (Suppl 20): 1-4.
65. Halbreich U (1997b) Premenstrual dysphoric disorders: A diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95: 169-176.
66. Halbreich U (1996) Premenstrual Syndromes. In: Halbreich U (ed) Balliere's clinical psychiatry: International practice and research. Bailliere Tindall, London, 667-686.
67. Halbreich U (1997c) Psychiatric disorders in women. In: Weller M, van Kammen D (eds) Progress in clinical psychiatry. Saunders, London, 96-115.
68. Halbreich U (1997d) Role of estrogen in postmenopausal depression. Neurology 48: S16-19.
69. Halbreich U (1999) RU-486, estrogen and leuprolide as treatment for PMS [abstract]. 30th Annual Meeting, ISPNE, Orlando, Florida.
70. Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part II: Effects on selected psychotropics. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: Sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 43-71.
71. Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part I: Physiological basis for effects. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: Sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 11-41.
72. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG (1989) Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 30: 405-411.
73. Hatotani N, Nishikubo M, Iitayama I (1979) Periodic psychosis in the female and the reproductive process. In: Zichella L, Pancheri P (eds) Psychoneuroendocrinology in reproduction. Elsevier North Holland, New York, 55-68.
74. Hurt SW, Schnurr PP, Severino SK, et al. (1992) Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149: 525-530.
75. Jensvold MF, Hamilton JA (1996) Sex and gender effects in psychopharmacology: Contributory factors and implications for pharmacotherapy. In: Halbreich U (ed) Psychiatric issues in women. Bailliere Tindall, London, 647-665.
76. Jensvold MF (1996) Nonpregnant reproductive-Age women, Part I: The menstrual cycle and psychopharmacology. In: Jensvold MF, Halbreich UH, Hamilton JA (eds) Psychopharmacology and women. American Psychiatric Press, Washington DC, 139-169.
77. Johnson SR (1987) The epidemiology and social impact of premenstrual symptoms. Clin Obstet 30: 369-384.
78. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996) The identification and validation of distinct depressive syndromes in a populationbased sample of female twins. Arch Gen Psychiatry 53: 391-399.
79. Kessler R (2000) Gender and mood disorders. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989-996.
80. Kessler RC, McGonagle KA, Zhao S, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8-19.
81. Kessler RC, Walters EE (1998) Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7: 3-14.
82. Kessler RC (1995) Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohan M, Zahner GEP (eds) Textbook in psychiatric epidemiology. Wiley, New York, 179-197.
83. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36: 550-554.
84. Kornstein SG, McEnany G (2000) Enhancing pharmacologic effects in the treatment of depression in women. J Clin Psychiatry 61 (Suppl 11): 18-27.
85. Kornstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in chronic major and double depression. J Affect Disord 60: 1-11.
86. Kornstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157: 1445-1452.
87. Kornstein SG, Schatzberg AF, Yonkers KA, et al. (1995) Gender differences in presentation of chronic major depression. Psychopharmacol Bull 31: 711-718.
88. Kornstein SG (1997) Gender differences in depression: Implications for treatment. J Clin Psychiatry 58 (Suppl 15): 12-18.
89. Kouri E, Halbreich U (1998) Psychotrophic effects of hormonal replacement therapy. Drugs of Today 34: 251-257.
90. Kumar R, Robson KM (1984) A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144: 35-47.
91. Leibenluft E, Hardin TA (1995) Gender differences in seasonal affective disorder. Depression 3: 13-19.
92. LeMeledo JM, Bradwein J, Koszycki D, Bichet D (1995) Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry 52: 605-606.
93. Lepage P, Steiner M (1991) Gender and serotonergic dyregulation: Implications for late luteal phase dysphoric disorder. In: Cassano GB, Akiskal HS (eds) Serotonin related psychiatric syndromes: Clinical and therapeutic links. Roy Soc Med Service Congress Symp Series No 165, London.
94. Lewinsohn PM, Rohde P, Seeley JR (1998) Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 18: 765-794.
95. Luggin R, Bernsted L, Petersson B, Jacobsen AT (1984) Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand 69: 461-465.
96. Luine VN (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484- 490.
97. Magos AL, Brincat M, Studd JWW (1986) Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo controlled study. BMJ 292: 1629-1633.
98. Maoz B, Durst N (1980) The effects of oestrogen therapy on the sex life of postmenopausal women. Maturitas 2: 327-336.
99. Matsumoto A, Arai Y, Osanai M (1985) Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 2: 412-418.
100. McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically-relevant basic sciences studies of gender differences and sex hormones effects. Psychopharmacol Bull 34: 251-259.
101. McEwen BS, Alves SE, Bulloch K (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48 (Suppl 7): S8-S15.
102. McEwen BS, Woolley CS (1994) Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29: 431-436.
103. McEwen BS (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12: 141-147.
104. Merikangas KR, Foeldenyl M, Angst J (1993) The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243: 23-32.
105. Michael C, Kantor H, Shore H (1970) Further psychometric evaluation of older women - the effect of estrogen administration. J Gerontol 25: 337-341.
106. Montgomery JC, Appleby L, Brincat M, et al. (1987) Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1: 297- 299.
107. Murray CJL, Lopez AD (1996) The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global burden of disease and injury series. The Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Boston, 43.
108. Muse K, Cetel N, Futterman L, Yen SC (1984) The premenstrual syndrome: effects of 'medical ovariectomy'. N Eng J Med 311: 1345-1349.
109. O'Hara MW, Swain AM (1996) Rates and risk of postpartum depression - A metaanalysis. Int Rev Psychiatry 8: 37-54.
110. O'Hara MW, Zekoski EM, Philipps LH, Wright EJ (1990) Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women. J Abnorm Psychol 99: 3-15.
111. Ohayon MM, Caulet M (1995) Insomnia and psychotropic drug consumption. Progr Neuropsychopharmacol Biol Psychiatry 19: 421-431.
112. Ohkura T, Teshima Y, Isse K (1994) Estrogen increases cerebral and cerebellar blood flow in postmenopausal women. Menopause 2: 13-18.
113. Palinkas LA, Barrett-Connor E (1992) Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80: 30-36.
114. Parry BL (1989) Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12: 207-220.
115. Paterson MEL (1982) A randomized double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climateric symptoms and biochemical parameters. Maturitas 4: 83-94.
116. Piletz JE, Halbreich U (2000) Imidazoline and alpha(2a)-Adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry 48: 932-939.
117. Prange AJ (1972) Estrogen may well affect response to antidepressant. JAMA 219: 143-144.
118. Price RA, Kidd KK, Weissman MM (1987) Early onset (under age 30 years) and panic disorder as markers etiologic homogeneity in major depression. Arch Gen Psychiatry 44: 434-440.
119. Ramcharan S, Love EJ, Fick GH, Goldfien A (1992) The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 45: 377-392.
120. Rawson NSB, D'Arcy C (1991) Sedative hypnotic drug use in Canada. Health Reports 3: 33-57.
121. Reighard FT, Evans ML (1995) Use of the Edinburgh Postnatal Depression Scale in a Southern, rural population in the United States. Progr Neuropsychophamacol Biol Psychiatry 19: 1219-1224.
122. Rivera-Tovar AD, Frank E (1990) Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147: 1634-1636.
123. Roy A, Gang P, Cole K, Rutsky M, Reese L, Weisbord J (1993) Use of Edinburgh Postnatal Depression Scale in a North American population. Progr Neuropsychophamacol Biol Psychiatry 17: 501-504.
124. Roy-Byrne PP, Rubinow DR, Hoban MC, Grover GN, Blank D (1987) TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 144: 480.
125. Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: Implications for affective regulation. Biol Psychiatry 44: 839-50.
126. Rubinow DR, Schmidt PJ, Roca CA (1998) Hormone measures in reproductive endocrine-related mood disorders: Diagnostic issues. Psychopharmacol Bull 34: 289-290.
127. Saletu B, Brandstatter N, Metkam M, et al. (1995) Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with trandermal oestradiol therapy in menopasual depression. Psychophamacology 122: 321-329.
128. Sandberg D, Endicott J, Harrison W, Nee J, Gorman J (1993) Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatr Res 46: 79-88.
129. Schmidt PJ, Nieman L, Danaceau MA, et al. (2000) Estrogen replacement in perimenopause- related depression: A preliminary report. Am J Obstet Gynecol 183: 414-420.
130. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209-216.
131. Schmidt PJ, Roca CA, Bloch M, Rubinow DR (1997) The perimenopause and affective disorders. Semin Reprod Endocrinol 15: 91-100.
132. Schneider LS, Small G, Clary C (1998) Estrogen replacement therapy and antidepressant response to sertraline [abstract]. Annual Meeting of the American Psychiatric Association, Toronto, Ontario.
133. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5: 97-106.
134. Schneider MA, Brotherton PL, Hailes J (1977) The effect of exogenous oestrogens on depression in menopausal women. Med J Aus 2: 162-163.
135. Seeman MV (2000) Mental illness in women. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989-996.
136. Shapira B, Oppenheim G, Zohar J, Segal M, Malach D, Belmaker RH (1985) Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20: 576-579.
137. Sherwin BB, Gelfand MM, Brender W (1985) Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47: 339-351.
138. Sherwin BB, Gelfand MM (1985) Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendoctrinology 10(3): 325-335.
139. Simpkins JW, Singh M, Bishop J (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15: S195-S197.
140. Singh M, Meyer EM, Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in Sprague-Dawley rats. Brain Res 644: 305-312.
141. Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and oestradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136: 2320-2324.
142. Skegg DCG, Doll R, Perry J (1977) Use of medicines in general practice. Br Med J 1: 1561-1563.
143. Steiner M, Born L, Marton P (2000) Menarche and mood disorders in adolescence. In: Steiner M, Yonkers K, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 247-268.
144. Steiner M, Steinberg S, Stewart D, et al. (1995) Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/premenstrual dysphoria collaborative studygroup. N Eng J Med 332: 1529-1534.
145. Steiner M, Wheadon D, Kreider M, Bushnell W (1993) Antidepressant response to paroxetine by gender (Abstract #462). Ann Meeting American Psychiatric Association, San Francisco.
146. Stewart DE, Boydell KM (1993) Psychologic distress during menopause: Associations across the reproductive life cycle. Int J Psychiatry Med 23: 157-162.
147. Strickler RC, Borth R, Cecutti A, et al. (1977) The role of oestrogen replacement in the climacteric syndrome. Psychol Med 7: 631-639.
148. Studd JWW, Smith RNJ (1994) Estrogens and depression in women. Menopause 1: 3-7.
149. Stunkard AJ, Fernstrom MH, Price A, Frank E (1990) Direction of weight change in recurrent depression: Consistency across episodes. Arch Gen Psych 47: 857-860.
150. Terry DJ, Mayocchi L, Hynes GJ (1996) Depressive symptomatology in new mothers: A stress and coping perspective. J Abnorm Psychol 105: 220-231.
151. Thompson J, Oswald I (1977) Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. BMJ 19: 1317-1319.
152. Troutman BR, Cutrona CE (1990) Nonpsychotic postpartum depression among adolescent mothers. J Abnorm Psychol 99: 69-78.
153. Van Valkingburg C, Akiskal HS, Puzantian V, Rosenthal T (1984) Anxious depression: Clinical, family history, and naturalistic outcome - comparisons with panic and major depressive disorders. J Affect Disord 6: 67-82.
154. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2: 730-732.
155. Weissman MM, Bland RC, Canino GJ, et al. (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293-299.
156. Weissman MM, Klerman GL (1977) Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34: 98-111.
157. Weissman MM, Livingston BM, Leaf PJ (1991) Affective disorders. In: Robins LN, Regier DA (eds) Psychiatric disorders in America. Free Press, New York.
158. Weissman MM (1979) The myth of involutional melancholia. Jama 242: 742-744.
159. West ED, Dally PJ (1992) Effect of iproniazid in depressive syndromes. BJM 1: 1491-1494.
160. Whiffen VE (1002) Is postpartum depression a distinct diagnosis? Clin Psychol Rev 12: 485-508.
161. Whiffen VE (1988) Vulnerability of postpartum depression: A prospective multivariate study. J Abnorm Psychol 97: 467-474.
162. Wikander I, Sundblad C, Andersch B et al. (1998) Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 18: 390-398.
163. Wiklund I, Karlberg J, Mattson L (1993) Quality of life menopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controled study. Am J Obstet Gynecol 168: 824-830.
164. Wolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12: 2549- 2554.
165. Woods NF, Most A, Dery GK (1982) Prevalence of perimenstrual symptoms. Am J Public Health 72: 1257-1264.
166. Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T (1996) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32: 41-46.
167. Yonkers KA, Kando JC, Cole JO, Blumenthal S (1992) Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587-595.
168. Yonkers KA, Kando JC, Hamilton JA, Halbreich U (2000) Gender differences in treatment of depression and anxiety. In: Halbreich U, Montgomery SA (eds) Pharmacotherapy for mood, anxiety, and cognitive disorders. American Psychiatric Press, Washington DC, 59-74.
169. Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB (1998) Is the course of panic disorder the same in women and men? Am J Psychiatry 155: 596-602.
170. Yonkers KA (1998) Assessing unipolar mood disorders in women. Psychopharmacol Bull 34: 261-266.
171. Young E, Korszun A (1998) Psychoneuroendocrinology of depression. Hypothalamicpituitary- gonadal axis. Psychiatr Clin North America 21: 309-323.
172. Young EA, Midgley AR, Carlson NE, Brown MB (2000) Alteration in the hypothalamic- pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 57: 1157-1162.
173. Zelkowitz P, Milet TH (1995) Screening for post-partum depression in a community sample. Can J Psychiatry 40: 80-86.